Skip to main content

Ketogenic Diet as Treatment Option for Infants with Intractable Epileptic Syndromes

  • Chapter
  • First Online:
Nutrition in Infancy

Abstract

A special diet for those suffering from epilepsy such as the ketogenic diet (KD) is a successful alternative treatment option in young children when treatment with different combinations of anti epileptic drugs (AEDs) fails.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 249.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Wheless JW. Nonpharmacologic treatment of the catastrophic epilepsies of childhood. Epilepsia. 2004;45 Suppl 5:17–22.

    Article  PubMed  Google Scholar 

  2. Wheless JW. History of ketogenic diet. In: Stafstrom CE, Rho JM, editors. Epilepsy and the ketogenic diet. 1st ed. Totowa, NJ: Humana; 2004. p. 349.

    Google Scholar 

  3. Freeman JM, Freeman JB, Kelly MT. The ketogenic diet: a treatment option for epilepsy. 3rd ed. New York: Demos Medical Publishing; 2000.

    Google Scholar 

  4. Levy R, Cooper P. Ketogenic diet for epilepsy. Cochrane Database Syst Rev. 2003;(3):CD001903.

    Google Scholar 

  5. Levy RG, Cooper PN, Giri P. Ketogenic diet and other dietary treatments for epilepsy. Cochrane Database Syst Rev. 2012;3:CD001903.

    Google Scholar 

  6. Neal EG, Chaffe H, Schwartz RH, et al. The ketogenic diet for the treatment of childhood epilepsy: a randomised controlled trial. Lancet Neurol. 2008;7(6):500–6.

    Article  PubMed  Google Scholar 

  7. Kossoff EH, Zupec-Kania BA, Amark PE, et al. Optimal clinical management of children receiving the ketogenic diet: recommendations of the International Ketogenic Diet Study Group. Epilepsia. 2009;50(2):304–17.

    Article  PubMed  Google Scholar 

  8. van den Hurk T, van der Louw E. Dietary treatment guideline for the ketogenic diet in children with refractory epilepsy. Evidence based manual for multidisciplinairy treatment. 1st ed. Utrecht: University Medical Center Utrecht, Department of Nutritional Sciences and Dietetics; 2011.

    Google Scholar 

  9. Kossoff EH. Infantile spasms. Neurologist. 2010;16(2):69–75.

    Article  PubMed  Google Scholar 

  10. Hancock EC, Osborne JP, Edwards SW. Treatment of infantile spasms. Cochrane Database Syst Rev. 2008(4):CD001770.

    Google Scholar 

  11. Darke K, Edwards SW, Hancock E, et al. Developmental and epilepsy outcomes at age 4 years in the UKISS trial comparing hormonal treatments to vigabatrin for infantile spasms: a multi-centre randomised trial. Arch Dis Child. 2010;95(5):382–6.

    Article  PubMed  Google Scholar 

  12. Elterman RD, Shields WD, Bittman RM, Torri SA, Sagar SM, Collins SD. Vigabatrin for the treatment of infantile spasms: final report of a randomized trial. J Child Neurol. 2010;25(11):1340–7.

    Article  PubMed  Google Scholar 

  13. Debus OM, Kurlemann G. Sulthiame in the primary therapy of West syndrome: a randomized double-blind placebo-controlled add-on trial on baseline pyridoxine medication. Epilepsia. 2004;45(2):103–8.

    Article  PubMed  CAS  Google Scholar 

  14. Kabir SM, Rajaraman C, Rittey C, Zaki HS, Kemeny AA, McMullan J. Vagus nerve stimulation in children with intractable epilepsy: indications, complications and outcome. Childs Nerv Syst. 2009;25(9):1097–100.

    Article  PubMed  CAS  Google Scholar 

  15. Loddenkemper T, Holland KD, Stanford LD, Kotagal P, Bingaman W, Wyllie E. Developmental outcome after epilepsy surgery in infancy. Pediatrics. 2007;119(5):930–5.

    Article  PubMed  Google Scholar 

  16. Pellock JM, Hrachovy R, Shinnar S, et al. Infantile spasms: a U.S. consensus report. Epilepsia. 2010;51(10):2175–89.

    Article  PubMed  Google Scholar 

  17. Nordli Jr DR, Kuroda MM, Carroll J, et al. Experience with the ketogenic diet in infants. Pediatrics. 2001;108(1):129–33.

    Article  PubMed  Google Scholar 

  18. Kossoff EH, Pyzik PL, McGrogan JR, Vining EP, Freeman JM. Efficacy of the ketogenic diet for infantile spasms. Pediatrics. 2002;109(5):780–3.

    Article  PubMed  Google Scholar 

  19. Eun SH, Kang HC, Kim DW, Kim HD. Ketogenic diet for treatment of infantile spasms. Brain Dev. 2006;28(9):566–71.

    Article  PubMed  Google Scholar 

  20. Kossoff EH, Hedderick EF, Turner Z, Freeman JM. A case–control evaluation of the ketogenic diet versus ACTH for new-onset infantile spasms. Epilepsia. 2008;49(9):1504–9.

    Article  PubMed  Google Scholar 

  21. Hong AM, Turner Z, Hamdy RF, Kossoff EH. Infantile spasms treated with the ketogenic diet: prospective single-center experience in 104 consecutive infants. Epilepsia. 2010;51(8):1403–7.

    Article  PubMed  Google Scholar 

  22. Freeman JM, Kossoff EH. Ketosis and the ketogenic diet, 2010: advances in treating epilepsy and other disorders. Adv Pediatr. 2010;57(1):315–29.

    Article  PubMed  Google Scholar 

  23. Sullivan PB. Feeding and Nutrition in children with neurodevelopmental disability. 1st ed. London: Mac Keith; 2009.

    Google Scholar 

  24. Kang HC, Lee YJ, Lee JS, et al. Comparison of short- versus long-term ketogenic diet for intractable infantile spasms. Epilepsia. 2011;52(4):781–7.

    Article  PubMed  Google Scholar 

  25. Patel A, Pyzik PL, Turner Z, Rubenstein JE, Kossoff EH. Long-term outcomes of children treated with the ketogenic diet in the past. Epilepsia. 2010;51(7):1277–82.

    Article  PubMed  Google Scholar 

  26. Wheless JW. Managing severe epilepsy syndromes of early childhood. J Child Neurol. 2009;24(8 Suppl):24S–32. quiz 33S-26S.

    Article  PubMed  Google Scholar 

  27. Conry JA. Pharmacologic treatment of the catastrophic epilepsies. Epilepsia. 2004;45 Suppl 5:12–6.

    Article  PubMed  CAS  Google Scholar 

  28. Jonas R, Asarnow RF, LoPresti C, et al. Surgery for symptomatic infant-onset epileptic encephalopathy with and without infantile spasms. Neurology. 2005;64(4):746–50.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Elles J. T. M. van der Louw R.D. .

Editor information

Editors and Affiliations

Appendices

Appendix 1: Diet Schedules for Infants

Example I: 9 Months Old (9 kg)

Bottle feeding/day

Ingredients/24 h

  • 70 g Ketocal 3:1®

  • 12 mL Calogen® neutral

  • Water until 800 mL of feeding

Supplement

  • 5 μg vitamin D solute into oil

Divided into

  • 3  ×  200 mL

  • 2  ×  100 mL

Breakfast

200 mL bottle feeding

Morning snack

Fruit at 2.5 g carbohydratea

25 g crème fraiche (35 g/100 gram fat)

100 mL bottle feeding

Afternoon

200 mL bottle feeding

Afternoon snack

Vegetables at 1 g carbohydratea

5 g vegetable oil

5 g fatty cheese (48 g fat/100 g)

100 mL bottle feeding

Evening meal

200 mL bottle feeding

aAccording to variation lists

Analysis

Calories per day

705

78 kcal/kg

Grams of protein

13

7 energy %

Grams of LCT fat

69

88 energy %

Grams of carbohydrates

9

5 energy %

Ratio

3:1

 

Example II: 9 Months Old (8.5 kg) with Decreased Resting Energy Expenditure

Bottle feeding/day

Ingredients/24 h

  • 85 g Ketocal® 3:1

  • 710 mL water

Supplement

  • 5 mg vitamin D solute in oil

Divided into

  • 5  ×  150 mL

Extra

  • 1  ×  100 mL water/sugar-free lemonade

Breakfast

150 mL bottle feeding

Morning

150 mL bottle feeding

100 mL sugar-free lemonade

Afternoon

150 mL bottle feeding

Afternoon snack

Vegetables/cream/oil/ cheese calculated based on analysis of 150 mL bottle feedinga

100 mL sugar-free lemonade

NB: when the child eats only 50% of his or her meal, supplement 75 mL

Bottle feeding

Evening

150 mL bottle feeding

aAnalysis of 150 mL bottle feeding made of 17 g Ketocal® 3:1:

119 kcal, 2.6 g protein, 12 g LCT fat, 1 g carbohydrate, ratio 3:1

Analysis

Calories per day

594

69 kcal/kg

Grams of protein

13

8 energy %

Grams of LCT fat

58

88 energy %

Grams of carbohydrates

6

4 energy %

Ratio

3:1

 

Appendix 2: Emergency Regimes in Case of Illness [8]

Use of ORS Junior

100 mL ORS Junior, prepared according to the information on the package, contains 22 g carbohydrate (2 sachets for 1 L)

  1. 1.

    1 sachet ORS Junior can be diluted into 1,000 mL water and contains 11 g carbohydrate.

  2. 2.

    The amount of ORS Junior depends on the carbohydrate content of the KD and must be calculated individually.

  3. 3.

    In daily practice, in the case of the classic KD, a limited amount of ORS Junior can be used.

Illness, fever with vomiting or diarrhea

Phase I

Give 24 h ORS Junior according to the preceding guidelines and calculated based on weight and age of individual child

Compensate each time vomiting and or diarrhea occurs with 10 mL ORS Junior/kg body weight

Use diet composition indicated in individual emergency plan

Phase II

In case of bottle feeding

Dilute bottle feeding 50–50 with water

Give numerous, smaller portions throughout day

In case of solid food

Calculate meals at a lower ratio than the usual diet (2.5:1 when normal 3:1, or 3:1 when normal 4:1)

Distribute the food over smaller portions

Compensate each vomiting/diarrhea episode with 10 mL ORS Junior/kg body weight

Use composition indicated in individual emergency plan

Intake of solid foods may be limited and can be accepted if child continues to feed from bottle

Phase III

If complaints subside, a switch can be made to the regular diet

Illness, fever without vomiting and/or diarrhea

Phase I

In case of bottle feeding

Dilute bottle feeding 50–50 with water

Give numerous, smaller portions throughout day

In case of solid food

Calculate meals at a lower ratio than the usual diet (2.5:1 when normal 3:1, or 3:1 when normal 4:1)

Distribute food over smaller portions

Compensate each vomiting/diarrhea episode with 10 mL ORS Junior/kg body weight

Use composition indicated in individual emergency plan

Intake of solid foods may be limited and can be accepted if child continues to feed from bottle

Phase II

If complaints subside, a switch can be made to the regular diet

If complaints do not subside, see advice under Phase I

First 24 h can be continued for a maximum of 2 days

Glossary

Infant

Child <12 months of age.

Infantile spasms (IS): or West syndrome

A form of severe epilepsy presenting between 3 and 10 months of age characterized by a brisk flexion or extension of the extremities, sometimes followed by a brief tonic posture, appearing in clusters and often occurring after sleep transition and accompanied by developmental regression. Characteristically interictal EEGs reveal hypsarrhytmia, high-amplitude, chaotic background pattern, and asynchronous slow waves intermixed with multifocal spikes.

Intractable epileptic syndrome

General term covering epileptic syndromes (like Ohtarara syndrome and West syndrome) that do not respond to initial treatment with (multiple) anti epileptic drug regimes.

Ohtahara syndrome

Identical to West syndrome but presenting before 3 months of age.

Ketogenic diet (KD)

High-fat, low-carbohydrate diet with adequate amount of protein that mimics the metabolic state of fasting during an anabolic situation.

Due to the lack of carbohydrates energy metabolism shifts from carbohydrate to fat burning for energy, which induces production of ketone bodies (aceto acetate, β (beta)-hydroxybutyrate and acetone) that can be measured in urine and blood.

An adequate level of ketosis is defined as 3–4  +  (8–16 mmol/L) ketones in urine or 2–5 mmol/L ­ketones in blood.

Ketogenic ratio

The ratio of ketone-producing foods in the diet (i.e. dietary fat). The most used ratio’s are 3:1 or 4:1. This means either 3 or 4 g of ketone-producing fat vs. 1 g non-ketone-producing protein and carbohydrates.

Rights and permissions

Reprints and permissions

Copyright information

© 2013 Springer Science+Business Media New York

About this chapter

Cite this chapter

van der Louw, E.J.T.M., Catsman-Berrevoets, C.E., van den Hurk, D.A.M., Olieman, J.F. (2013). Ketogenic Diet as Treatment Option for Infants with Intractable Epileptic Syndromes. In: Watson, R., Grimble, G., Preedy, V., Zibadi, S. (eds) Nutrition in Infancy. Nutrition and Health. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-62703-254-4_3

Download citation

  • DOI: https://doi.org/10.1007/978-1-62703-254-4_3

  • Published:

  • Publisher Name: Humana Press, Totowa, NJ

  • Print ISBN: 978-1-62703-253-7

  • Online ISBN: 978-1-62703-254-4

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics